Ozgur Sahin

Medical University Of South Carolina

$6,265,859

Attributed

$6,265,859

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY2019–25

$2M$1.5M$1M$500K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$6,265,859 · 4

By mechanism

R01$3,138,859 · 2

R42$2,456,500 · 1

P20$670,500 · 1

Top collaborators

No co-investigators on record.

Most similar at Medical University Of South Carolina

Same institution · by research overlap

Chiara Luberto$3,768,458
Dieter Haemmerich$4,432,514
Naren L Banik$13,192,318
Jurgen Tiberius Rohr$6,950,139
Yusuf Awni Hannun$36,962,745

Others in their field

Other Emerging Leaders on “Malignant Breast Neoplasm”

Greg Yothers · University Of Chicago$35,003,821
Olwen Hahn · Brigham And Women'S Hospital$32,076,706
Leonard Freedman · Leidos Biomedical Research, Inc.$21,750,066
Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
Leonard Freedmand · Leidos Biomedical Research, Inc.$12,635,631
Jessica Scott · Sloan-Kettering Inst Can Research$10,553,540

Research focus

Malignant Breast NeoplasmIn VivoBreast Cancer PatientUnited States National Institutes Of HealthIn VitroToxic EffectTriple-Negative Invasive Breast CarcinomaClinically RelevantBreast Cancer ModelExtracellular MatrixCellsOrganoidsPatient Derived Xenograft ModelIntegrinsOverexpressionThree Dimensional Cell CultureMammary NeoplasmsProteinsPublic HealthPhenotypeBreastAggressive Breast CancerApoptosisDisability